Celcuity Inc.: Form 10-K for the period ended Dec 31, 2021
Filed with the SEC on Mar 23, 2022 and accepted by EDGAR at Mar 23, 2022, 21:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 12 months2021-01-01 to 2021-12-31 | $25.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | −$28.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-01-01 to 2021-12-31 | $1.3m | us-gaap:InterestExpense |
| Net income | 12 months2021-01-01 to 2021-12-31 | −$29.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | −$2.21 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | −$20.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | $81.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-12-31 | $84.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-12-31 | $85.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $85.9m | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $2.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | $17.2m | us-gaap:Liabilities |
| Long-term debt | At period end2021-12-31 | $16.0m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2021-12-31 | $68.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-22-007560. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.